Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Emily Riehm Meier; Theodore Johnson; Kerice Pinkney; Maria C. Velez; Naynesh Kamani; Isaac Odame

doi:10.1002/pbc.27105

Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Emily Riehm Meier, Theodore Johnson, Kerice Pinkney, Maria C. Velez, Naynesh Kamani, Isaac Odame

Pediatric Hematology/Oncology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

Original language	English (US)
Article number	e27105
Journal	Pediatric Blood and Cancer
Volume	65
Issue number	9
DOIs	https://doi.org/10.1002/pbc.27105
State	Published - Sep 2018

Keywords

diversity
healthcare disparities
hematopoietic stem cell transplant
hydroxyurea
sickle cell anemia

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.27105

Cite this

@article{3a86a4b575284504974e5b6a1b90a57a,

title = "Access to hematopoietic stem cell transplant for patients with sickle cell anemia",

abstract = "Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.",

keywords = "diversity, healthcare disparities, hematopoietic stem cell transplant, hydroxyurea, sickle cell anemia",

author = "Meier, {Emily Riehm} and Theodore Johnson and Kerice Pinkney and Velez, {Maria C.} and Naynesh Kamani and Isaac Odame",

note = "Publisher Copyright: {\textcopyright} 2018 Wiley Periodicals, Inc.",

year = "2018",

month = sep,

doi = "10.1002/pbc.27105",

language = "English (US)",

volume = "65",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "9",

}

TY - JOUR

T1 - Access to hematopoietic stem cell transplant for patients with sickle cell anemia

AU - Meier, Emily Riehm

AU - Johnson, Theodore

AU - Pinkney, Kerice

AU - Velez, Maria C.

AU - Kamani, Naynesh

AU - Odame, Isaac

PY - 2018/9

Y1 - 2018/9

N2 - Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

AB - Hematopoietic stem cell transplantation (HSCT) is a curative therapy for patients with phenotypically severe sickle cell anemia, and survival rates following matched-sibling HSCT are very high. However, despite cure rates much higher than HSCT for malignant diseases, the field has been slow to adopt this treatment modality for sickle cell anemia. This article explores some of the social forces that may contribute to this dichotomy.

KW - diversity

KW - healthcare disparities

KW - hematopoietic stem cell transplant

KW - hydroxyurea

KW - sickle cell anemia

UR - http://www.scopus.com/inward/record.url?scp=85046078246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046078246&partnerID=8YFLogxK

U2 - 10.1002/pbc.27105

DO - 10.1002/pbc.27105

M3 - Review article

C2 - 29693782

AN - SCOPUS:85046078246

SN - 1545-5009

VL - 65

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 9

M1 - e27105

ER -

Access to hematopoietic stem cell transplant for patients with sickle cell anemia

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this